Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women - Concepedia

Concepedia

Publication | Open Access

Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women

DOI Full Paper Access

28

Citations

36

References

2023

Year

Mattias Hammarström, Marike Gabrielson, Alessio Crippa, Andrea Discacciati, Martin Eklund, Cecilia Lundholm, L. Magnus Bäcklund, Yvonne Wengström, Signe Borgquist, Jenny Bergqvist,

British Journal of Cancer

Abstract

ClinicalTrials.gov ID: NCT03346200.

References

	Year	Citations
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer Reiki Nishimura, Tomofumi Osako, Yasuyuki Nishiyama, Oncology	2013	13.2K
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, JNCI Journal of the National Cancer Institute	1998	5.5K
Tamoxifen for early breast cancer: an overview of the randomised trials The Lancet Breast OncologyEarly Breast CancerMedicineRandomised TrialsCancer Management	1998	4.1K
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials The Lancet Breast OncologyMedicineRandomised TrialsPatient-level Meta-analysisPharmacology	2011	3K
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial Christina Davies, Hongchao Pan, Jon Godwin, The Lancet Breast OncologyLong-term EffectsMedicineRandomised TrialGynecology	2012	2K
Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes<SUBTITLE>The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial</SUBTITLE> Victor G. Vogel JAMA	2006	1.6K
The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress Russell K. Portenoy, Howard T. Thaler, Alice B. Kornblith, European Journal of Cancer Psychological Co-morbiditiesSymptom PrevalencePsychiatryPatient-reported OutcomeMental Health	1994	1.6K
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial Trevor J. Powles, Rosalind A. Eeles, S. Ashley, The Lancet Interim AnalysisBreast OncologyMedicineEpidemiology Of CancerClinical Trials	1998	887
First results from the International Breast Cancer Intervention Study (IBIS-I): a randomised prevention trial J Cuzick, JF Forbes, Rob Edwards, The Lancet Breast OncologyPreventive MedicineCancer ScreeningGlobal HealthMedicine	2002	742
Health-Related Quality of Life and Tamoxifen in Breast Cancer Prevention: A Report From the National Surgical Adjuvant Breast and Bowel Project P-1 Study Richard Day, Joseph P. Costantino, Walter M. Cronin, Journal of Clinical Oncology	1999	442

Page 1